3rd Quarter - Report
CAPITOL COUNSEL LLC for IPSEN BIOPHARMACEUTICALS, INC.
Firm
Income
$30,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Ensure Medicare beneficiary access to Medicare covered prescription drugs and enable beneficiaries to spread cost-sharing requirements, including monitoring implementation of related provisions in the Inflation Reduction Act, P.L. 117-169.
Foreign entity interest: Foreign parent affected by policies affecting U.S. subsidiary.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY CARROLL | — |
| LUKE HATZIS | — |
| ANN JABLON | — |
| JOHN MARTIN | — |
| CHARLES PATRICK MICHAELS | — |
Taxation/Internal Revenue Code TAX
Issues related to international tax.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHANNON FINLEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.